Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

62.84
-0.7600-1.19%
Post-market: 63.300.4600+0.73%19:45 EDT
Volume:12.21M
Turnover:770.41M
Market Cap:127.93B
PE:13.83
High:64.35
Open:64.08
Low:62.52
Close:63.60
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:1.53
T/O Rate:0.60%
Dividend:2.51
Dividend Rate:4.00%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:5.73
PE(LYR):18.16

Loading ...

Cytokinetics - Files Complaint Against Bristol-Myers Squibb and Myokardia - SEC Filing

THOMSON REUTERS
·
Aug 13

Cytokinetics - Demands Trial by Jury on All Triable Issues - SEC Filing

THOMSON REUTERS
·
Aug 13

Cytokinetics Sues Bristol Myers, MyoKardia Seeking Ruling on Myqorzo Patent Dispute

Reuters
·
Aug 13

Atrium Gets $15M in Latest Milestone Payment from Bristol Myers Squibb

Dow Jones
·
Aug 13

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

THOMSON REUTERS
·
Aug 13

Atrium Therapeutics - Eligible for up to $1.35 Bln R&D Milestones, $825 Mln Commercial Milestones, Tiered Royalties

THOMSON REUTERS
·
Aug 13

Atrium Therapeutics - Bristol Myers Squibb to Fund All Future Development and Commercialization Activities

THOMSON REUTERS
·
Aug 13

Switzerland's PolyPeptide H1 Revenue Rises on Stronger Metabolic Therapeutics Demand

Reuters
·
Aug 13

Why Bristol Myers Squibb (BMY) Is Back In The Spotlight

Simply Wall St.
·
Aug 13

BMY Expands Melanoma Immunotherapy Footprint With New Phase 4 Trial in India

TIPRANKS
·
Aug 13

Huang's $500 Billion Financing Plan Splits Markets: Asset Managers Rally as Tech Stocks Slide for Second Day

Deep News
·
Aug 12

Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Savara Q2 Loss Widens as Operating Expenses Rise

Reuters
·
Aug 12

Investor backlash killed AstraZeneca, Bristol Myers tie-up, FT reports

TIPRANKS
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Legend Biotech Q2 Revenue Beats Estimates on Commercial Expansion

Reuters
·
Aug 11

$400 Billion Merger Talks Collapse: AstraZeneca and Bristol-Myers Squibb Negotiations Fall Apart

Deep News
·
Aug 11

Replimune Jumps After $150 Mln Equity Offering for Skin Cancer Drug

Reuters
·
Aug 11

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

Bristol-Myers Squibb Company - Bms Expects to Create 2,000 Construction and Indirect Jobs Between 2027–2030

THOMSON REUTERS
·
Aug 10